Your search returned 3 results.

Results
	1.	Interferon Beta-1a (AVONEX®) as a Treatment Option for Untreated Patients with Multiple Sclerosis (AXIOM): A Prospective, Observational Study. [electronic resource] by Kleinschnitz, Christoph Niemczyk, Gabriele Rehberg-Weber, Karin Wernsdörfer, Colin Producer: 20160329 In: International journal of molecular sciences vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Adherence and cost in multiple sclerosis patients treated with IM IFN beta-1a: impact of the CARE patient management program. [electronic resource] by Katsarava, Zaza Ehlken, Birgit Limmroth, Volker Taipale, Kirsi Patel, Sarita Noemi Niemczyk, Gabriele Rehberg-Weber, Karin Wernsdörfer, Colin Producer: 20160505 In: BMC neurology vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Quality Assessment in Multiple Sclerosis Therapy (QUASIMS): a comparison of interferon beta therapies for relapsing-remitting multiple sclerosis. [electronic resource] by Limmroth, Volker Malessa, Rolf Zettl, Uwe Klaus Koehler, Jürgen Japp, Gudrun Haller, Peter Elias, Wolfgang Obhof, Winfried Viehöver, Andrea Meier, Uwe Brosig, Arne Hasford, Joerg Putzki, Norman Kalski, Gabriele Wernsdörfer, Colin Producer: 20070710 In: Journal of neurology vol. 254 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)